Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Non Operating Income (2017 - 2025)

Lipocine (LPCN) has disclosed Non Operating Income for 10 consecutive years, with $174209.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 57.68% year-over-year to $174209.0, compared with a TTM value of $835061.0 through Sep 2025, down 32.6%, and an annual FY2024 reading of $1.2 million, down 26.31% over the prior year.
  • Non Operating Income was $174209.0 for Q3 2025 at Lipocine, down from $198637.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $895754.0 in Q2 2022 and bottomed at -$3.8 million in Q2 2021.
  • Average Non Operating Income over 5 years is $48619.5, with a median of $291292.0 recorded in 2024.
  • Peak annual rise in Non Operating Income hit 632.02% in 2021, while the deepest fall reached 155.07% in 2021.
  • Year by year, Non Operating Income stood at -$159926.0 in 2021, then surged by 307.22% to $331401.0 in 2022, then fell by 5.96% to $311653.0 in 2023, then fell by 24.05% to $236704.0 in 2024, then fell by 26.4% to $174209.0 in 2025.
  • Business Quant data shows Non Operating Income for LPCN at $174209.0 in Q3 2025, $198637.0 in Q2 2025, and $225511.0 in Q1 2025.